Development of an Ointment Formulation Using Hot-Melt Extrusion Technology

AAPS PharmSciTech

Volumn 17, Issue 1, 2016, Pages 158-166

  Bhagurkar, Ajinkya M ^a   Angamuthu, Muralikrishnan ^a   Patil, Hemlata ^a   Tiwari, Roshan V ^a   Maurya, Abhijeet ^a   Hashemnejad, Seyed Meysam ^b   Kundu, Santanu ^b   Murthy, S Narasimha ^a   Repka, Michael A ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

hot melt extrusion; lidocaine; ointment; PEG; texture analyzer

Indexed keywords

LIDOCAINE; MACROGOL 3350; MACROGOL 400; OINTMENT BASE; DRUG CARRIER; OINTMENT;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FLOW RATE; HOT MELT EXTRUSION; IN VITRO STUDY; MODEL; OINTMENT; PH MEASUREMENT; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS TECHNOLOGY; SHEAR RATE; TEMPERATURE; VISCOSITY; X RAY DIFFRACTION; CHEMISTRY; FLOW KINETICS; HEAT; MEDICINAL CHEMISTRY; PROCEDURES;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; HOT TEMPERATURE; OINTMENTS; RHEOLOGY;

EID: 84959170323     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-015-0453-3     Document Type: Article

References (28)

1. "Pharmaceutical Machinery." Ointment Manufacturing Plant, Planetary Mixer, Tube Filling Machine. http://www.pharmaceuticalmachinery.in/ointment_section.htm. Accessed 14-04-15.
2. "U.S. Food and Drug Administration." Topical Drug Products (7/94). http://www.fda.gov/ICECI/Inspections/InspectionGuides/ucm074933.htm. Accessed 23-04-15.
3. Patil H, Tiwari RV, Repka MA. Hot melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmaSciTech. 2015. doi:10.1208/s 12249-015-0360-7.
4. Shah S, Repka MA. Melt extrusion in drug delivery: three decades of progress. In: Repka MA, Langley N, DiNunzio J, editors. Melt extrusion: materials, technology and drug product design. NY: Springer; 2013. p. 4–5.
5. Repka MA, Majumdar S, Battu SK, Srirangam R, Upadhye S. Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv. 2008;5:1357–76.
6. Repka MA, Shah S, Lu J, Maddineni S, Morott J, Patwardhan K, et al. Melt extrusion: process to product. Expert Opin Drug Deliv. 2012;9:105–25.
7. Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D. A review of hot melt extrusion: process technology to pharmaceutical products. ISRN Pharm. 2012;2012:1–9.
8. Groningsson K, Lindgren JE, Lundberg E, Sandberg R, Wahlen A. Lidocaine base and lidocaine hydrochloride. Analytical profiles of drug substances. New York: Academic; 1985. p. 209–13.
9. http://www.drugbank.ca/drugs/DB00281 Accessed 24-05-15.
10. Fougera® (lidocaine ointment USP, 5%) [package insert]. Fougera Pharmaceuticals. Inc. Melville, NY.
11. The pharmaceutics and compounding laboratory. http://pharmlabs.unc.edu/labs/ointments/bases.htm Accessed 18-04-15.
12. Patil H, Kulkarni V, Majumdar S, Repka MA. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion. Int J Pharm. 2014;471:153–6.
13. Patil H, Feng X, Ye X, Majumdar S, Repka MA. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS J. 2015;17:194–205.
14. Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Fetoh E, Nutan MTH. In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations. Pharm Dev Technol. 2001;16:497–510.
15. Repka MA, Gutta K, Prodduturi S, Munjal M, Stodghill SP. Characterization of cellulosic hot melt extruded films containing lidocaine. Eur J Pharm Biopharm. 2004;59:189–96.
16. Tai A, Bianchini R, Jachowicz J. Texture analysis of cosmetic/pharmaceutical raw materials and formulations. Int J Cosmet Sci. 2014;36:291–304.
17. Shah V, Elkins J, Williams R. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm Dev Technol. 1999;4:377–85.
18. Thakker KD, Chern H. Development and validation of in vitro release tests for semisolid dosage forms—case study. Disso Tech. 2003;10:10–5.
19. FDA-SUPAC-SS. Guidance for Industry. SUPAC-SS Non-sterile semisolid dosage forms. Scale-up and postapproval changes: chemistry, manufacturing and controls. In vitro Release Testing and In Vivo Bioequivalence Documentation; 1997. pp. 19–24.
20. Brown MB, Turner R, Lim ST. Topical product formulation development. In: Benson HAE, Watkinson AC, editors. Transdermal and topical drug delivery: principles and practice. Hoboken: Wiley; 2012. p. 255–84.
21. Olejink A, Goscianska J, Nowak I. Active compounds release from semisolid dosage forms. J Pharm Sci. 2012;101:4032–45.
22. Shah VP, Elkins J, Lam SY, Skelly JP. Determination of in vitro drug release from hydrocortisone creams. Int J Pharm. 1989;53:53–9.
23. Nallagundla S, Patnala S, Kanfer I. Comparison of in vitro release rates of acyclovir from cream formulations using vertical diffusion cells. AAPS PharmaSciTech. 2014;15(4):994–9.
24. Inoue Y, Furuya K, Maeda R, Murata I, Kanamoto I. Assessment of the physical properties and stability of mixtures of tetracycline hydrochloride ointment and acyclovir cream. Int J Pharm. 2013;447:158–64.
25. Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibach H, et al. Topical and transdermal drug products. Pharmacopeial Forum. 2009;35:750–64.
26. Krishnaiah YSR, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, et al. Development of performance matrix for generic product equivalence of acyclovir topical cream. Int J Pharm. 2014;475:110–22.
27. TA Instruments, Thermal analysis and rheology http://tainstruments.co.jp/application/pdf/Rheology_Library/Application_Briefs/RH058.PDF Accessed 13-08-15.
28. Adeyeye MC, Jain AC, Ghorab MKM, Reilly WJ. Viscoelastic evaluation of topical creams containing microcrystalline cellulose/sodium carboxymethyl cellulose as stabilizer. AAPS PharmaSciTech. 2002; 3:(2) article 8:1–10.